Researchers have identified a protein that powers the virulence of the bacteria that causes gonorrhea, opening the possibility of a new target for antibiotics and, even better, a vaccine.
The findings, published today in PLOS Pathogens, are especially important since the microbe, Neisseria gonorrhoeae, is considered a “superbug” because of its resistance to all classes of antibiotics available for treating infections.
Gonorrhea, a sexually transmitted disease that results in 78 million new cases worldwide each year, is highly damaging if untreated or improperly treated.
It can lead to endometritis, pelvic inflammatory disease, ectopic pregnancy, epididymitis and infertility. Babies born to infected mothers are at increased risk of blindness.
“The infections very often are silent,” said Oregon State University researcher Aleksandra Sikora. “Up to 50 percent of infected women don’t have symptoms, but those asymptomatic cases can still lead to some very severe consequences for the patient’s reproductive health, miscarriage or premature delivery.”
The need for better antibiotic therapy, and a vaccine, is pressing. N. gonorrhoeae strains resistant to the last effective treatment options have emerged, and failures in treatment are occurring.
Sikora and her research team at the OSU/OHSU College of Pharmacy and Ann Jerse’s lab at the Uniformed Services University of the Health Sciences in Bethesda, Maryland, collaborated to discover a novel lipoprotein that N. gonorrhoeae uses to defeat the body’s first line of innate immune defense.
The body relies on enzymes known as lysozymes that, as their name suggests, thwart bacteria by causing their cell wall to lyse, or break apart. Lysozymes are abundant both in epithelial cells, which make up the tissue on the outside of organs and the inside of body cavities, and in the phagocytic cells that protect the body by ingesting foreign particles and bacteria.
In turn, many gram-negative bacteria – characterized by their cell envelope that includes a protective outer membrane – have developed ways of defeating lysozymes. Prior to the work by Sikora’s team, however, only one lysozyme-fighting protein had been discovered in the Neisseria genus.
Now that new targets have been identified, they can be explored as bullseye candidates for new antibiotics or a vaccine – if the lysozyme inhibitor can itself be inhibited, then the bacteria’s infection-causing ability is greatly reduced.
Sikora and her collaborators named the new protein SliC, short for surface-exposed lysozyme inhibitor of c-type lysozyme.
Studying SliC’s function in culture as well as in a gonorrhea mouse model – mice were infected with N. gonorrhoeae, then checked for SliC expression at one, three and five days – researchers determined the protein was essential to bacterial colonization because of its anti-lysozyme role.
“This is the first time an animal model has been used to demonstrate a lysozyme inhibitor’s role in gonorrhea infection,” Sikora said. “Together, all of our experiments show how important the lysozyme inhibitor is. This is very exciting.”
Receive an email update when we add a new GONORRHEA article.
The Latest on: Gonorrhea
via Google News
The Latest on: Gonorrhea
- Antibiotics May No Longer Work, But Here Are 3 Herbal Treatments For Staphylococcus, Gonorrhea and other infections on October 6, 2018 at 2:00 am
Doctors and other medical institutions, have warned that mere toilet infections, if not properly treated can cause staphylococcus, pelvic inflammatory disease (PID), which is one of the major culprit ... […]
- Take steps to guard against the spread of sexually transmitted diseases on October 5, 2018 at 7:23 am
Laboratory tests are used to identify the presence of syphilis serology, Neisseria gonorrhea and chlamydia. The cumulative number of cases is then reported to the Texas Department of State Health ... […]
- Free condoms now officially being handed out in Montgomery County high schools on October 4, 2018 at 8:28 pm
The county's chief health officer says the program is needed due to a spike in sexually transmitted infections in the area, including double digit increases in both chlamydia and gonorrhea. […]
- Inconsequential News Quiz: Thurston's Navy Edition on October 4, 2018 at 7:27 am
What was it? A) Breaking a four-year streak, not a single person in Blytheville contracted gonorrhea over the weekend. B) Thanks to a freak solar flare, the CBS affiliate came in clear on local TVs fo... […]
- Regional cases of STIs on the rise last 5 years on October 3, 2018 at 10:54 pm
For example, syphilis cases increased 283 percent during that time period. Gonorrhea cases jumped nearly 216 percent, and the number of chlamydia cases grew 24 percent. Comparing reports from 2016 and ... […]
- Gonorrhea could be antibiotic resistant in the next decade on October 1, 2018 at 10:46 pm
With the Centers for Disease Control and Prevention calling it an “epidemic” and without the demand for pharmaceutical companies to produce new drugs, the U.S. could see antibiotic resistance to sexua... […]
- Chlamydia, Gonorrhea and Syphilis All on the Rise on September 26, 2018 at 12:58 pm
Each year, the Centers for Disease Control and Prevention conducts a national overview of the sexually transmitted diseases across the United States and the results for 2017 are in. And the conclusion... […]
- More cases of syphilis and gonorrhea in Norfolk since HIV drug launched on September 26, 2018 at 7:56 am
Norfolk has been part of a national study of HIV pre-exposure prophylaxis (PrEP), a medication which prevents people catching HIV. In Norwich alone 30 people who are considered at high risk of getting ... […]
- In NYC, gonorrhea, chlamydia cases up, syphilis down on September 25, 2018 at 2:02 am
The number of people with sexually transmitted infections spiked in New York City last year, according to statistics released Tuesday by the CDC. There were 23,491 cases of gonorrhea reported in New Y... […]
via Bing News